Sai Life Sciences Limited
SAILIFE
Rank in Stocks
#4711
Sai Life Sciences Limited operates as a contract research, development, and... Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It provides medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is based in Hyderabad, India.
Share Price
$14.78
Market Cap
$3.14B
Change (1 day)
-4.18%
Change (1 year)
47.89%
Country
IN
Trade Sai Life Sciences Limited (SAILIFE)
Category
Healthcare
Operating Margin for Sai Life Sciences Limited (SAILIFE)
Operating Margin as of October 2026 TTM: 21.47%
According to Sai Life Sciences Limited latest financial reports and stock price the company's current Operating Margin (TTM) is 21.47%. At the end of 2025 the company had an Operating Margin of 16.11%.
Operating Margin history for Sai Life Sciences Limited from 2025 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 21.47% | 33.27% |
| 2025 | 16.11% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 17.98% | -99.16% |
US
|
|
| 20.38% | -99.05% |
US
|
|
| -10.70% | -100.50% |
US
|
|
| 42.43% | -98.02% |
CN
|
|
| 22.23% | -98.96% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.